ArticleTheranostics2020
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma.
Open access · goldAbstract read
In one paragraph
Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 32 citations in OpenAlex.
- Exploratory Multi-Platform Bioinformatic Analysis of MEAK7 and Its Molecular, Survival, and Immune Associations in Pancreatic Ductal Adenocarcinoma.International journal of molecular sciences · 2026Article
- CDCP1-targeted antibody-drug conjugates and immunocytokines for cancer therapy.Cancer chemotherapy and pharmacology · 2026Article
- High CDCP1 Expression Reflects Immune and Stromal Remodeling and Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma.World journal of oncology · 2026Article
- SMYD3-CDCP1 Axis Drives EMT and CAF Activation in Colorectal Cancer and Is Targetable for Oxaliplatin Sensitization.Biomedicines · 2025Article
- CDCP1-targeting ADC outperforms standard therapies in Ras-mutant pancreatic cancer.Molecular therapy. Oncology · 2025Article
- An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum.Journal of gastroenterology · 2025Article
- Recent Advances in Small Molecular PET Tracers for Pancreatic Cancer Diagnosis: Preclinical Stage.Mini reviews in medicinal chemistry · 2025Review
- Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future.Cancers · 2023Review
- Theranostic Targeting of CUB Domain-Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023Article
- Mechanistic insights into CDCP1 clustering on non-small-cell lung cancer membranes revealed by super-resolution fluorescent imaging.iScience · 2023Article
- CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression.Scientific reports · 2023Article
- CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022Article
- Targeting CDCP1 gene transcription coactivated by BRD4 and CBP/p300 in castration-resistant prostate cancer.Oncogene · 2022Article
- Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers.The Journal of clinical investigation · 2022Article
- The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets.Biomolecules · 2022Review
- ImmunoPET: Antibody-Based PET Imaging in Solid Tumors.Frontiers in medicine · 2022Review
- CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy.Theranostics · 2022Article
- Review
- Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1.Nature chemical biology · 2021Article
- Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?International journal of molecular sciences · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 8 institutions in 3 countries.
Thomas KryzaMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia.
Tashbib KhanMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia.
Simon PuttickCommonwealth Scientific and Industrial Research Organisation, Herston, QLD, Australia.
Chao LiChina Medical University, Shenyang, China.
Kamil A SokolowskiPreclinical Imaging Facility, Translational Research Institute, Woolloongabba, QLD, Australia.
Brian Wc TsePreclinical Imaging Facility, Translational Research Institute, Woolloongabba, QLD, Australia.
Tahleesa CudaMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia.
Nicholas LyonsMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia.
Madeline GoughMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia.
Julia YinThe Kinghorn Cancer Centre, The Garvan Institute of Medical Research, Sydney, NSW, Australia.
Ashleigh ParkinThe Kinghorn Cancer Centre, The Garvan Institute of Medical Research, Sydney, NSW, Australia.
Elena I DeryuginaThe Scripps Research Institute, La Jolla, CA, USA.
James P QuigleyThe Scripps Research Institute, La Jolla, CA, USA.
Ruby H P LawBiomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia.
James C WhisstockBiomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia.
Andrew D RiddellFaculty of Medicine, The University of Queensland, St. Lucia, QLD, Australia.
Andrew P BarbourUpper Gastrointestinal/Soft Tissue Unit, Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
David K WyldFaculty of Medicine, The University of Queensland, St. Lucia, QLD, Australia.
Paul A ThomasFaculty of Medicine, The University of Queensland, St. Lucia, QLD, Australia.
Stephen RoseCommonwealth Scientific and Industrial Research Organisation, Herston, QLD, Australia.
Cameron E SnellMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia.
Marina PajicThe Kinghorn Cancer Centre, The Garvan Institute of Medical Research, Sydney, NSW, Australia.
Yaowu HeMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia.
John D HooperMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia.
Australian Regenerative Medicine Institute · AUCommonwealth Scientific and Industrial Research Organisation · AUMater Health Services · AUScripps Research Institute · USUniversity of Queensland · AUChina Medical University · CNRedcliffe Hospital · AURoyal Brisbane and Women's Hospital · AU
Funding
Transmembrane Proteins Involved in Human Tumor ExpansionR01CA105412 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI QUIGLEY, JAMES P · 2004 to 2020
$5.8MNCI NIH HHS R01 CA105412
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsAntigens, NeoplasmBiomarkers, TumorCarcinoma, Pancreatic DuctalCell Adhesion MoleculesCell Line, TumorDisease ProgressionGene Expression Regulation, NeoplasticHumansMicePancreatic NeoplasmsPrecision MedicineProteolysisAntigens, NeoplasmBiomarkers, TumorCDCP1 protein, humanCell Adhesion MoleculesCDCP1monoclonal-antibodypancreatic cancerPET-CTtheranostics
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.